Average Co-Inventor Count = 4.14
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Beth Israel Deaconess Medical Center, Inc. (6 from 517 patents)
2. University of Massachusetts (4 from 1,553 patents)
3. The General Hospital Corporation (2 from 2,893 patents)
4. The Brigham and Women's Hospital, Inc. (2 from 1,373 patents)
6 patents:
1. 11702659 - Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
2. 11345917 - Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
3. 10519451 - Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
4. 10272136 - Diagnostic and therapeutic uses of gelsolin in renal failure
5. 9862952 - Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
6. 9575072 - Diagnostic and therapeutic uses of gelsolin in renal failure